EUCTR2012-005398-30-IT
Active, Not Recruiting
Phase 1
Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT instudy of neuroblastoma: comparison with 123I-MIBG scintigraphy - dopa
AZIENDA OSPEDALIERA OSPEDALI GALLIERA0 sites40 target enrollmentJanuary 11, 2013
Conditionspatients wiht NB onset with high probability to return in stages 3 and 4 of the disease on the basis of the ultrasound images or TC. May also be included with the two-stage amplification of N-MYCMedDRA version: 14.1Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- patients wiht NB onset with high probability to return in stages 3 and 4 of the disease on the basis of the ultrasound images or TC. May also be included with the two-stage amplification of N-MYC
- Sponsor
- AZIENDA OSPEDALIERA OSPEDALI GALLIERA
- Enrollment
- 40
- Status
- Active, Not Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Age \> 12 months \<18 years
- •\- Patients suffering from NB onset with high probability to return in stages 3 and 4 of the disease on the basis of
- •ultrasound or CT images. May also be included with the two\-stage amplification of N\-MYC
- •\- Histological diagnosis of NB
- •\- No previous chemotherapy lines with the exception of steroid treatment
- •\- written informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
Exclusion Criteria
- •\- Comorbidity for other cancers
- •\- Hypersensitivity to the active substance or excipients in the radiopharmaceutical.
- •\- Any other medical condition at the discretion of the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Diagnostic performance and prognostic significance of myocardial pathological findings in cardiomyopathycardiomyopathyJPRN-UMIN000041174Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University900
Completed
N/A
Clinical evaluation of prognostic indicators using vital signs in critically ill patientsCritically ill patientsJPRN-UMIN000048711Tokyo Women's Medical University1,238
Recruiting
N/A
Clinical evaluation of prognostic indicators using vital signs in critically ill patientsJPRN-UMIN000050855St. Marianna University School of Medicine1,000
Not Yet Recruiting
N/A
Prediction of survival by physicians and assessment of symptoms in patients with liver, pancreatic and gallbladder cancers in a palliative care settingCTRI/2022/08/044932Tata Memorial Hospital
Recruiting
N/A
The diagnostic accuracy and treatment evaluation of the patients with outdoor activity or Severe fever with thrombocytopenia syndromeCertain infectious and parasitic diseasesKCT0005114Chosun University Hospital250